BioSpace News Archive

Johnson & Johnson announced that, in light of the evolving situation with the coronavirus outbreak, it will reschedule its 2020 Medical Devices Business Review that was planned to take place on May 13, 2020.

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

Abstracts Highlighting RECELL Clinical and Health Economic Benefits Included in Journal of Burn Care & Research Supplement

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

Blue Cross Blue Shield of Arizona announced that it will waive cost sharing for insured members who receive care for COVID-19 related treatment from in-network providers through May 2020.

Invitae Corporation announced the pricing of an underwritten public offering of 17,777,778 shares of its common stock at a price to the public of $9.00 per share.

MiraDx, a Los Angeles-based molecular genetics company, has transitioned its CLIA-certified lab to provide COVID-19 tests for essential workers, prioritizing hospital and field-based healthcare workers who are providing direct patient care as well as first responders

Improved patient outcomes without complicated surgeries create a favorable use case for corneal implant’s application in the cases of presbyopia. The reversible nature of the implant accounts for its popularity amongst the patients as well as medical professionals.

The demand for an effective treatment for chronic diseases drives the adoption of cell culture media. The robust and effective impact of cell culture technology makes it an ideal medium for developing antibodies, making it a vital aspect of the healthcare sector. The augmenting application of cell culture media in the development of biopharmaceutical products is propelling market growth.

Perimeter Solutions, the world leader in fire safety chemical solutions, announced today that its Spanish operation has diverted some of its existing manufacturing capacity currently producing fire suppressant foams to the production of consumer-grade sanitizer to assist the government of the Principality of Asturias in protecting healthcare and essential personnel in the region.